Difference between revisions of "Template:Histamine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
|||
| Line 6: | Line 6: | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | | group1 = [[ | + | | group1 = [[Receptor (biochemistry)|Receptor]]<br /><center><small>([[Ligand (biochemistry)|ligand]]s)</small></center> |
| list1 = {{Navbox subgroup | | list1 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| Line 86: | Line 86: | ||
* [[Tolpropamine]] | * [[Tolpropamine]] | ||
* [[Tripelennamine]] | * [[Tripelennamine]] | ||
| − | * [[Triprolidine]] | + | * [[Triprolidine]]; ''2nd generation'': [[Acrivastine]] |
| − | |||
| − | |||
* [[Alinastine]] | * [[Alinastine]] | ||
* [[Astemizole]] | * [[Astemizole]] | ||
| Line 128: | Line 126: | ||
* [[Temelastine]] | * [[Temelastine]] | ||
* [[Terfenadine]] | * [[Terfenadine]] | ||
| − | * [[Zepastine]] | + | * [[Zepastine]]; ''3rd generation'': [[Desloratadine]] |
| − | |||
| − | |||
* [[Fexofenadine]] | * [[Fexofenadine]] | ||
| − | * [[Levocetirizine]] | + | * [[Levocetirizine]]; ''Ungrouped'': [[Belarizine]] |
| − | |||
| − | |||
* [[Efletirizine]] | * [[Efletirizine]] | ||
* [[Elbanizine]] | * [[Elbanizine]] | ||
| Line 144: | Line 138: | ||
* [[Trelnarizine]] | * [[Trelnarizine]] | ||
* [[Trenizine]] | * [[Trenizine]] | ||
| − | * [[Vapitadine]] | + | * [[Vapitadine]]; ''Miscellaneous'': [[Tricyclic antidepressant]]s ([[amitriptyline]], |
| − | |||
| − | |||
* [[doxepin]], | * [[doxepin]], | ||
* [[trimipramine]], etc) | * [[trimipramine]], etc) | ||
| Line 234: | Line 226: | ||
}} | }} | ||
| − | | group2 = [[Neurotransmitter transporter|Transporter]] | + | | group2 = [[Neurotransmitter transporter|Transporter]]<br /><center><small>([[Reuptake inhibitor|blocker]]s)</small></center> |
| list2 = {{Navbox subgroup | | list2 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| Line 240: | Line 232: | ||
| group1 = [[Vesicular monoamine transporter|VMAT]] | | group1 = [[Vesicular monoamine transporter|VMAT]] | ||
| list1 = | | list1 = | ||
| − | * | + | * [[Ibogaine]] |
* [[Reserpine]] | * [[Reserpine]] | ||
* [[Tetrabenazine]] | * [[Tetrabenazine]] | ||
| Line 246: | Line 238: | ||
}} | }} | ||
| − | | group3 = [[Enzyme]] | + | | group3 = [[Enzyme]]<br /><center><small>([[Enzyme inhibitor|inhibitor]]s)</small></center> |
| list3 = {{Navbox subgroup | | list3 = {{Navbox subgroup | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| Line 252: | Line 244: | ||
| group1 = [[Histidine decarboxylase|HDC]] | | group1 = [[Histidine decarboxylase|HDC]] | ||
| list1 = | | list1 = | ||
| − | * | + | * [[(+)-Catechin|Catechin]] |
* [[Meciadanol]] | * [[Meciadanol]] | ||
* [[Naringenin]] | * [[Naringenin]] | ||
| Line 259: | Line 251: | ||
| group2 = [[Histamine N-methyltransferase|HNMT]] | | group2 = [[Histamine N-methyltransferase|HNMT]] | ||
| list2 = | | list2 = | ||
| − | * | + | * [[Amodiaquine]] |
* [[Diphenhydramine]] | * [[Diphenhydramine]] | ||
* [[Harmaline]] | * [[Harmaline]] | ||
| Line 269: | Line 261: | ||
| group3 = [[Diamine oxidase|DAO]] | | group3 = [[Diamine oxidase|DAO]] | ||
| list3 = | | list3 = | ||
| − | * | + | * [[Aminoguanidine]] |
}} | }} | ||
| Line 277: | Line 269: | ||
| groupstyle = background-color: LightYellow | | groupstyle = background-color: LightYellow | ||
| − | | group1 = Endogenous | + | | group1 = [[Endogenous]] |
| list1 = | | list1 = | ||
* [[Histamine]]; ''Precursors:'' [[L-Histidine|<small>L</small>-Histidine]]; ''Cofactors:'' [[Vitamin B6|Vitamin B<sub>6</sub>]] | * [[Histamine]]; ''Precursors:'' [[L-Histidine|<small>L</small>-Histidine]]; ''Cofactors:'' [[Vitamin B6|Vitamin B<sub>6</sub>]] | ||
Revision as of 09:04, 9 November 2014
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Histamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Histamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Histamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.